Lofexidine for acute opioid withdrawal: A clinical case series

INTRODUCTION: Maintaining abstinence through the opioid withdrawal period is a substantial barrier to treatment for patients with opioid use disorder. The alpha-2 agonist lofexidine has demonstrated efficacy and safety in clinical trials, but pragmatic studies describing its use in clinical practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Renfro, Mandy L., Loera, Lindsey J., Tirado, Carlos F., Hill, Lucas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534813/
https://www.ncbi.nlm.nih.gov/pubmed/33062550
http://dx.doi.org/10.9740/mhc.2020.09.259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534813/
https://www.ncbi.nlm.nih.gov/pubmed/33062550
http://dx.doi.org/10.9740/mhc.2020.09.259

Ejemplares similares